Craig Lindsley

March 14, 2013

Lindsley honored for impact on medicinal chemistry field

Vanderbilt University’s Craig Lindsley, Ph.D., is the 2013 recipient of the Philip S. Portoghese Lectureship, awarded jointly by the Journal of Medicinal Chemistry and the American Chemical Society (ACS) Division of Medicinal Chemistry.

By VUMC News and Communications
October 18, 2012

Nobel in Chemistry reveals VU ties that bind

Several Vanderbilt researchers have collaborated with this year’s Nobel Chemistry winners.

By Bill Snyder
September 21, 2012

VU, Bristol-Myers to collaborate on Parkinson’s therapies

Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.

By Bill Snyder
August 30, 2012

Event celebrates Vanderbilt endowed chair holders

Twelve Vanderbilt University faculty members were honored for extraordinary contributions to their respective fields during an Aug. 28 celebration of endowed chair holders at the Student Life Center.

By VUMC News and Communications
Brain and doorway concept
April 6, 2012

Minds wide open: Neuroscience at Vanderbilt

Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.

By Bill Snyder
September 30, 2011

Drug-like molecules aimed at improving treatment of Parkinson’s

Drug-like molecules described by Vanderbilt researchers could lead to Parkinson’s treatments with fewer side effects.

By Bill Snyder
March 11, 2011

Neuroscience drug discovery center opens at Vanderbilt

Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain.
By Bill Snyder